Weibin Xie
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 7
- Molecular Biology top 10%
- Epigenetics and DNA Methylation 7
- RNA modifications and cancer 6
-
- Ferroptosis and cancer prognosis 4
- Prostate Cancer Treatment and Research 4
- Renal cell carcinoma treatment 3
-
- Bladder and Urothelial Cancer Treatments 12
- Urinary and Genital Oncology Studies 6
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Weibin Xie
29 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Cancer Research 575
- Radiology, Nuclear Medicine and Imaging 292
- Molecular Biology 789
- Pulmonary and Respiratory Medicine 316
- Oncology 207
Countries citing papers authored by Weibin Xie
This map shows the geographic impact of Weibin Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weibin Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weibin Xie more than expected).
Fields of papers citing papers by Weibin Xie
This network shows the impact of papers produced by Weibin Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weibin Xie. The network helps show where Weibin Xie may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Weibin Xie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 3 | |
| 4 | 2023 | 0 | |
| 5 | 2022 | 7 | |
| 6 | 2022 | 7 | |
| 7 | 2021 | 4 | |
| 8 | 2020 | 10 | |
| 9 | 2020 | 20 | |
| 10 | 2020 | 2 | |
| 11 | 2020 | 140 | |
| 12 | 2019 | 124 | |
| 13 | 2019 | 79 | |
| 14 | 2019 | 30 | |
| 15 | 2018 | 180 | |
| 16 | A Radiomics Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Bladder Cancerbreakdown → | 2017 | 313 |
| 17 | 2017 | 156 | |
| 18 | 2015 | 16 | |
| 19 | 2015 | 94 | |
| 20 | 2013 | 2 |
About Weibin Xie
Weibin Xie is a scholar working on Cancer Research, Transplantation and Surgery, having authored 31 papers that have together received 1.6k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (12 papers), Epigenetics and DNA Methylation (7 papers), Cancer-related molecular mechanisms research (7 papers), RNA modifications and cancer (6 papers), Urinary and Genital Oncology Studies (6 papers), Ferroptosis and cancer prognosis (4 papers), Prostate Cancer Treatment and Research (4 papers) and Renal cell carcinoma treatment (3 papers). The work is most often cited by research in Cancer Research (575 citations), Radiology, Nuclear Medicine and Imaging (292 citations) and Molecular Biology (789 citations). Weibin Xie has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Tianxin Lin, Jian Huang, Junjiong Zheng, Xu Chen, Jian Huang, Shaoxu Wu, Hao Yu, Jinli Han, Wen Dong and Ruihui Xie.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.